Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Cerilliant
Baxter
Mallinckrodt
US Army
Accenture
Fish and Richardson
Dow
Johnson and Johnson

Generated: June 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 085222

« Back to Dashboard

NDA 085222 describes QUINORA, which is a drug marketed by Key Pharms and Schering and is included in two NDAs. Additional details are available on the QUINORA profile page.

The generic ingredient in QUINORA is quinidine sulfate. There are twenty-seven drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the quinidine sulfate profile page.
Summary for 085222
Tradename:QUINORA
Applicant:Schering
Ingredient:quinidine sulfate
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength300MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Fuji
Medtronic
Moodys
McKinsey
US Department of Justice
AstraZeneca
UBS
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.